Pipeline

multimmune´s goal is to build a well-staged pipeline of differentiated products for the targeted therapy of cancer. All product candidates are directed against the tumor specific target Hsp70.

Product	Product class	Target	Indications	Technology
ENKASTIM-ev (ex vivo)	Activated human NK cells	Hsp70-expressing tumor cells	Various cancers (lung, breast, colon, pancreas, head/neck, melanoma, leukemia, lymphoma)	Specific activation of Natural Killer cells (ex vivo)
ENKASTIM-iv (in vivo)	Synthetic peptide / cancer vaccine	Hsp70-expressing tumor cells	Various cancers	Specific in vivo activation of Natural Killer cells
mi-TUMEX	Monoclonal antibody	Hsp70-expressing tumor cells	Various cancers	Specific immunotherapy; ADCC
mi-APO	Protein	Hsp70-expressing tumor cells	Various cancers	Tumor specific induction of apoptosis

Status